Form 4: Washington Trust Bancorp EVP Kathleen Ryan Reports Acquisition of Shares
SEC Form 4
Kathleen Ryan, EVP and Chief Wealth Management Officer of Washington Trust Bancorp, reports acquiring 3,100 shares of common stock and discloses beneficial ownership of securities.
Summary
- Kathleen A. Ryan, EVP and Chief Wealth Management Officer of Washington Trust Bancorp Inc. (WASH), filed a Form 4 on March 21, 2024, regarding changes in beneficial ownership.
- On March 19, 2024, Ms. Ryan acquired 3,100 shares of Common Stock at $0.
- Following the transaction, Ms. Ryan directly owns 4,811 shares of Common Stock.
- Ms. Ryan also indirectly owns 4,362 shares of Common Stock through the Kathleen Ryan Declaration of Trust dated March 7, 2008, as amended.
- Ms. Ryan also owns stock options to buy 2,000 shares at $40.25 expiring on 10/18/2026 and 1,800 shares at $58.05 expiring on 10/17/2027.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock ownership changes. The acquisition of shares by an executive is generally viewed as a slightly positive sign.
Positives
- The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Executive stock ownership is a common practice in the financial industry, aligning management's interests with those of shareholders.
Stakeholder Impact
- Increased executive ownership could align management's interests more closely with shareholders.
Key Dates
| Date | Description |
|---|---|
| March 7, 2008 | Date of The Kathleen Ryan Declaration of Trust, as amended |
| October 18, 2019 | Date of Stock Option grant (right to buy) at $40.25 |
| October 17, 2020 | Date of Stock Option grant (right to buy) at $58.05 |
| March 19, 2024 | Date of transaction: Acquisition of 3,100 shares of Common Stock |
| March 21, 2024 | Date of Form 4 filing |
| October 17, 2027 | Expiration date of Stock Option (right to buy) at $58.05 |
| October 18, 2026 | Expiration date of Stock Option (right to buy) at $40.25 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.